Ecstasy use-Parkinson's disease link tenuous

Mov Disord. 2004 Nov;19(11):1386. doi: 10.1002/mds.20223.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Administration, Oral
  • Adrenergic Uptake Inhibitors / toxicity*
  • Dose-Response Relationship, Drug
  • Hallucinogens / toxicity*
  • Humans
  • Injections, Subcutaneous
  • N-Methyl-3,4-methylenedioxyamphetamine / toxicity*
  • Parkinson Disease, Secondary / chemically induced*
  • Risk

Substances

  • Adrenergic Uptake Inhibitors
  • Hallucinogens
  • N-Methyl-3,4-methylenedioxyamphetamine